humanitarian
Archived signal
Human medicines European public assessment report (EPAR): Galafold, migalastat, Date of authorisation: 25/05/2016, Revision: 19, Status: Authorised
Human medicines European public assessment report (EPAR): Ablymico, liraglutide, Date of authorisation: 15/07/2026, Revision: 1, Status: Authorised
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
3 reports · 1 sources
EMA What Is NewHuman medicines European public assessment report (EPAR): Galafold, migalastat, Date of authorisation: 25/05/2016, Revision: 19, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Tecvayli, teclistamab, Date of authorisation: 23/08/2022, Revision: 11, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Vabysmo, faricimab, Date of authorisation: 15/09/2022, Revision: 11, Status: Authorised3 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources
Corroboration 2→1 sourcesP2 · 99% quality · 1 source